Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years
Ali Bazarbachi(American University of Beirut), Mohamad Mohty(Sorbonne Université), Alexandros Spyridonidis(General University Hospital of Patras), Dietrich W. Beelen(Essen University Hospital), Didier Blaise(Institut Paoli-Calmettes), Fabio Ciceri(Vita-Salute San Raffaele University), Victoria Potter(King's College Hospital NHS Foundation Trust), Jaime Sanz(Hospital Universitari i Politècnic La Fe), Myriam Labopin(Sorbonne Université), Riitta Niittyvuopio, Christoph Schmid(University Hospital Augsburg), Arnon Nagler(Sheba Medical Center), Igor Wolfgang Blau(Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie), Iman Abou Dalle(American University of Beirut Medical Center), Gesine Bug(Goethe University Frankfurt), Gèrard Socié(Hôpital Saint-Louis), Bipin N. Savani(Vanderbilt University Medical Center), Jordi Esteve(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Cited by 81
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k